Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GenturaDx Awarded Fifth Patent on Innovative Sample Prep Design

Published: Monday, March 26, 2012
Last Updated: Monday, March 26, 2012
Bookmark and Share
GenturaDx has been awarded its fifth patent from the U.S. patent office, which covers aspects of the sample cassette utilized by the IDbox™.

GenturaDx, has announced that is has been awarded its fifth patent from the U.S. patent office (U.S. Patent No. 8,124,024), which covers aspects of the sample cassette utilized by the IDbox™. The GenturaDx cassette design is part of the company's proprietary fully automated method of integrating extraction and purification of nucleic acids along with amplification and detection capabilities within the IDbox. This patent is specifically related to innovations within the integrated cassette that reduce the risk of Polymerase Chain Reaction (PCR) contamination that can cause false positive or erroneous results. By automating this important process, human error is minimized.

"The award of this patent supports our continued vision of bringing the highest quality of molecular diagnostic products to clinicians and patients. By simplifying these complex processes, we enable more health care providers with the most sensitive and accurate molecular tests," said GenturaDx Chief Scientific Officer Jesus Ching, Ph.D.

The fully integrated and automated design of the IDbox system will bring an easy-to-use, cost-effective and highly sensitive molecular testing capability to hospital laboratories. These laboratories will benefit from the decreased labor and enhanced workflow, while clinicians will benefit from receiving the most accurate result with rapid turnaround that ultimately allows for faster treatment and management of the patient. The company is currently performing clinical beta studies and heading towards clinical trials in third quarter 2012.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenturaDx Announces Addition to Board of Directors
The newly appointed member, Michael Treble, is currently chairman and CEO of Axela, Inc. The five current directors will remain on the board.
Thursday, January 12, 2012
Scientific News
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Gene Analysis System Could Accelerate Pace of Research on the Space Station
The WetLab-2 system will enable spaceflight genomic studies involving a wide variety of biospecimen types in the unique microgravity environment of space.
Liquid Biopsy for NSCLC
'Liquid biopsy' blood test accurately detects key genetic mutations in most common form of lung cancer, study finds.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Seeing Cell to Cell Differences
Seeing differences between individual cells for first time explains symptoms of rare genetic disorders, finds penn study.
Circular RNAs Implicated in Cancer
Circular RNAs – like their protein counterparts – are also affected by genomic rearrangements in cancer, resulting in abnormal fusions.
Know Thy Helicobacter pylori
Non-invasive method for genotyping H.pylori developed.
Zika Test Authorized for Emergency Use
n response to a request from the CDC, the FDA has issued an Emergency Use Authorization (EUA) for a diagnostic tool for Zika virus that will be distributed to qualified laboratories.
Lighting Up Disease-Carrying Mosquitoes
Sandia’s QUASR enables speedy, accurate detection of West Nile and other viruses.
Ultra-Sensitive Test for Cancers, HIV
Test developed that is thousands of times more sensitive than current diagnostics.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!